Mark Cuban Cost Plus Drug Company, HealthDyne Finalize Pharmacy Partnership
Partnership intends to reduce treatment costs, while also increasing medication access.
HealthDyne, a provider of digital pharmacy services and Cost Plus Drugs have partnered up, as the public benefit corporation looks to expand its pharmacy operations. The involved parties note that the future of healthcare is increasingly digital, presenting an opportunity to "unwind" the healthcare delivery system.
"Our company was created to help solve the ongoing challenges of patients not being able to afford medications and supplies," says Alex Oshmyansky, CEO of Cost Plus Drugs. "We set out to provide a new way for patients to receive their treatments at an affordable price. We already offer transparent, low prices to cash-pay consumers but are excited to partner with HealthDyne to further reduce costs, increase medication access, and deliver an unprecedented patient experience."
